148 related articles for article (PubMed ID: 31686753)
1. Prognostic Value of HER-2/neu Gene Amplification in Epithelial Ovarian Carcinoma.
Pankaj S; Kumari J; Choudhary V; Kumari A; Kumari S; Kumari A; Nazneen S; Madhawi R; Kumar S
J Obstet Gynaecol India; 2019 Oct; 69(Suppl 2):177-181. PubMed ID: 31686753
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer.
Wang D; Zhu H; Ye Q; Wang C; Xu Y
Medicine (Baltimore); 2016 Feb; 95(8):e2803. PubMed ID: 26937910
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of HER-2/neu expression in epithelial ovarian cancer: a systematic review and meta-analysis.
Wang K; Guan C; Yu J; Jin X; Sun L; Zheng L; Xia L; Zhang Y
Oncotarget; 2017 Sep; 8(43):75528-75543. PubMed ID: 29088888
[TBL] [Abstract][Full Text] [Related]
4. Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study.
Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Bock JE; Glud E; Nørgaard-Pedersen B; Høgdall CK
Cancer; 2003 Jul; 98(1):66-73. PubMed ID: 12833457
[TBL] [Abstract][Full Text] [Related]
5. Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications.
Iqbal N; Iqbal N
Mol Biol Int; 2014; 2014():852748. PubMed ID: 25276427
[TBL] [Abstract][Full Text] [Related]
6. The role of the HER-2/neu oncogene in gynecologic cancers.
Cirisano FD; Karlan BY
J Soc Gynecol Investig; 1996; 3(3):99-105. PubMed ID: 8796816
[TBL] [Abstract][Full Text] [Related]
7. [Overexpression and prognostic value of p53 and HER2/neu proteins in benign ovarian tissue and in ovarian cancer].
Coronado Martín PJ; Fasero Laiz M; García Santos J; Ramírez Mena M; Vidart Aragón JA
Med Clin (Barc); 2007 Jan; 128(1):1-6. PubMed ID: 17266884
[TBL] [Abstract][Full Text] [Related]
8. HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance. Clinical study.
Verri E; Guglielmini P; Puntoni M; Perdelli L; Papadia A; Lorenzi P; Rubagotti A; Ragni N; Boccardo F
Oncology; 2005; 68(2-3):154-61. PubMed ID: 16020953
[TBL] [Abstract][Full Text] [Related]
9. Human epidermal growth factor receptor 2 neu expression in head and neck squamous cell cancers and its clinicopathological correlation: Results from an Indian cancer center.
Vats S; Ganesh MS; Agarwal A
Indian J Pathol Microbiol; 2018; 61(3):313-318. PubMed ID: 30004046
[TBL] [Abstract][Full Text] [Related]
10. HER 2/neu Overexpression in Oral Squamous Cell Carcinoma and Its Clinico-Pathological Association at a Tertiary Care Center in Eastern India.
Rout T; Singh A; Epari V; Mohanty D; Sahu M; Nayak P; Ludam R; Tudu P; Agrawala S
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2430-2434. PubMed ID: 36452802
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of HER-2/neu overexpression in gastric carcinoma using a tissue microarray.
Rakhshani N; Kalantari E; Bakhti H; Sohrabi MR; Mehrazma M
Asian Pac J Cancer Prev; 2014; 15(18):7597-602. PubMed ID: 25292034
[TBL] [Abstract][Full Text] [Related]
12. Quantitative real-time PCR assay with immunohistochemical evaluation of HER2/neu oncogene in breast cancer patients and its correlation with clinicopathological findings.
Gheni N; Westenberg D
Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S123-S128. PubMed ID: 32108644
[TBL] [Abstract][Full Text] [Related]
13. HER-2/neu amplification is an independent prognostic factor in gastric cancer.
Park DI; Yun JW; Park JH; Oh SJ; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Yoo CH; Son BH; Cho EY; Chae SW; Kim EJ; Sohn JH; Ryu SH; Sepulveda AR
Dig Dis Sci; 2006 Aug; 51(8):1371-9. PubMed ID: 16868827
[TBL] [Abstract][Full Text] [Related]
14. Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing.
Schmidt M; Lewark B; Kohlschmidt N; Glawatz C; Steiner E; Tanner B; Pilch H; Weikel W; Kölbl H; Lehr HA
Breast Cancer Res; 2005; 7(2):R256-66. PubMed ID: 15743506
[TBL] [Abstract][Full Text] [Related]
15. HER2 Oncogene Amplification and Immunohistochemical Profiling in Gastric Adenocarcinoma.
Raj N; Verma D; Kumar A; Rai P; Rao RN
Discoveries (Craiova); 2018 Dec; 6(4):e83. PubMed ID: 32309603
[No Abstract] [Full Text] [Related]
16. Combined Expression of HGFR with Her2/neu, EGFR, IGF1R, Mucin-1 and Integrin α2β1 Is Associated with Aggressive Epithelial Ovarian Cancer.
Czogalla B; Dötzer K; Sigrüner N; von Koch FE; Brambs CE; Anthuber S; Frangini S; Burges A; Werner J; Mahner S; Mayer B
Biomedicines; 2022 Oct; 10(11):. PubMed ID: 36359213
[TBL] [Abstract][Full Text] [Related]
17. HER-2/neu overexpression is an independent prognostic factor for intestinal-type and early-stage gastric cancer patients.
Liu W; Zhong S; Chen J; Yu Y
J Clin Gastroenterol; 2012 Apr; 46(4):e31-7. PubMed ID: 22064554
[TBL] [Abstract][Full Text] [Related]
18. The Prognostic Significance of the Overexpression of HER-2/ neu in Korean Gastric Carcinomas and the In Vitro Effects of Anti-HER-2/neu Antibody on Cell Growth in the Gastric Carcinoma Cell Lines.
Im SA; Lee KE; Nam E; Nam SH; Kim DY; Seong CM; Park HY; Han WS; Seoh JY; Lee SN
Cancer Res Treat; 2003 Apr; 35(2):109-16. PubMed ID: 26680923
[TBL] [Abstract][Full Text] [Related]
19. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.
Ross JS; Fletcher JA
Stem Cells; 1998; 16(6):413-28. PubMed ID: 9831867
[TBL] [Abstract][Full Text] [Related]
20. Her-2/neu gene amplification in low to moderately expressing breast cancers: possible role of chromosome 17/Her-2/neu polysomy.
Bose S; Mohammed M; Shintaku P; Rao PN
Breast J; 2001; 7(5):337-44. PubMed ID: 11906444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
